Autopsy report · NCT00594906

Use of Teriparatide to Accelerate Fracture Healing

“The study was terminated due to poor enrollment.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 4 years 6 months before it stopped.
• 10 participants enrolled.
• Results were posted on the registry 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Rochester

Sponsor type

University, hospital or other

Conditions

Pelvic Fracture

Interventions

Teriparatide; Placebo

Participants

10

Sites

1

Countries

United States

Trials that died the same way

• A Study of Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer
  “The study was terminated due to low enrollment.” (97% match in meaning)
• Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
  “the study was terminated early due to poor enrollment” (96% match in meaning)
• BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
  “Study was terminated due to low enrollment.” (96% match in meaning)
• A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
  “Study was terminated due to poor enrollment” (95% match in meaning)
• A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
  “This study was terminated early due to poor enrollment.” (95% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.